Exploring the Hidden Challenges of India’s Emerging Weight-Loss Drug Market

In the bustling city of Mumbai, Saloni Khera’s battle with weight gain highlights a concerning trend in post-pandemic India. After contracting Covid-19, Khera experienced a significant increase in weight, ballooning to 153.5 kg within six months. This rapid gain was exacerbated by long Covid, a condition that leaves many with lingering health issues, along with her own pre-diabetic status and hormonal imbalances.

Khera’s struggle with obesity, which she describes as a lifelong challenge akin to diabetes or hypertension, is emblematic of a larger issue affecting countless individuals. Her numerous attempts at weight loss, including extreme diets that led her to survive on only water for a week, proved futile. “Every time I shed 15 kg, I ended up gaining back 25 kg,” she lamented, illustrating the frustrating cycle many face.

In light of her health concerns and the desire to start a family, Khera sought medical advice from a gynaecologist in Ahmedabad. Understanding the importance of her fitness journey, the doctor referred her to an endocrinologist, who recommended an innovative weight-loss solution: Mounjaro. This injectable medication, known scientifically as Tirzepatide, has shown promise in helping patients shed more than 20% of their body weight by mimicking hormones that regulate appetite and glucose levels.

The emergence of weight-loss drugs like Mounjaro reflects a growing market in India, where obesity rates are on the rise. The World Health Organization has identified obesity as a significant public health challenge, with cultural factors and lifestyle choices contributing to the epidemic. As demand for effective solutions increases, it raises questions about the accessibility and safety of such medications.

While the promise of rapid weight loss is appealing, the darker side of this booming market cannot be ignored. Concerns regarding the long-term effects of these drugs, potential dependency, and the risk of misdiagnosis loom large. As more individuals consider pharmacological solutions to combat obesity, it is critical to navigate this uncharted territory with caution and ensure that comprehensive lifestyle changes accompany any medical interventions.

Source: scroll.in